| # | Title | Journal | Year | Citations |
|---|
| 1 | COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates | Vaccines | 2021 | 1,332 |
| 2 | Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China | Vaccines | 2020 | 666 |
| 3 | Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review | Vaccines | 2021 | 577 |
| 4 | Peptide Vaccine: Progress and Challenges | Vaccines | 2014 | 518 |
| 5 | Vaccine Adjuvants: from 1920 to 2015 and Beyond | Vaccines | 2015 | 488 |
| 6 | High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries | Vaccines | 2021 | 448 |
| 7 | Factors Associated with COVID-19 Vaccine Hesitancy | Vaccines | 2021 | 443 |
| 8 | COVID-19 Vaccine Acceptance among Health Care Workers in the United States | Vaccines | 2021 | 419 |
| 9 | Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting | Vaccines | 2016 | 372 |
| 10 | Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States | Vaccines | 2020 | 371 |
| 11 | TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis | Vaccines | 2017 | 356 |
| 12 | Developments in Viral Vector-Based Vaccines | Vaccines | 2014 | 319 |
| 13 | Nanomaterial Delivery Systems for mRNA Vaccines | Vaccines | 2021 | 310 |
| 14 | The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression | Vaccines | 2016 | 296 |
| 15 | Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy | Vaccines | 2021 | 291 |
| 16 | COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries | Vaccines | 2021 | 290 |
| 17 | The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance | Vaccines | 2016 | 286 |
| 18 | The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity | Vaccines | 2015 | 285 |
| 19 | Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination | Vaccines | 2021 | 284 |
| 20 | A Comparison of Plasmid DNA and mRNA as Vaccine Technologies | Vaccines | 2019 | 266 |
| 21 | Recent Advances in Subunit Vaccine Carriers | Vaccines | 2016 | 231 |
| 22 | Progress and Prospects on Vaccine Development against SARS-CoV-2 | Vaccines | 2020 | 229 |
| 23 | Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials | Vaccines | 2021 | 228 |
| 24 | Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy | Vaccines | 2015 | 225 |
| 25 | Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines | Vaccines | 2021 | 222 |
| 26 | Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19 | Vaccines | 2021 | 217 |
| 27 | Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries | Vaccines | 2021 | 207 |
| 28 | Whole Tumor Antigen Vaccines: Where Are We? | Vaccines | 2015 | 203 |
| 29 | Willingness to Receive COVID-19 Vaccination in Japan | Vaccines | 2021 | 203 |
| 30 | Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic | Vaccines | 2021 | 196 |
| 31 | Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys | Vaccines | 2021 | 188 |
| 32 | Vaccine Knowledge, Awareness and Hesitancy: A Cross Sectional Survey among Parents Residing at Sandakan District, Sabah | Vaccines | 2021 | 179 |
| 33 | SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond | Vaccines | 2021 | 175 |
| 34 | Cathelicidins: Immunomodulatory Antimicrobials | Vaccines | 2018 | 162 |
| 35 | Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm | Vaccines | 2021 | 152 |
| 36 | Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines | Vaccines | 2015 | 151 |
| 37 | Immune History and Influenza Vaccine Effectiveness | Vaccines | 2018 | 148 |
| 38 | Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines | Vaccines | 2021 | 146 |
| 39 | Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection | Vaccines | 2022 | 144 |
| 40 | Cholera Toxin Subunit B as Adjuvant––An Accelerator in Protective Immunity and a Break in Autoimmunity | Vaccines | 2015 | 140 |
| 41 | Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects | Vaccines | 2021 | 140 |
| 42 | M2e-Based Universal Influenza A Vaccines | Vaccines | 2015 | 133 |
| 43 | Relationship between Citizens’ Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis | Vaccines | 2020 | 132 |
| 44 | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations | Vaccines | 2021 | 132 |
| 45 | Human Papillomavirus Vaccines: An Updated Review | Vaccines | 2020 | 130 |
| 46 | Approaches and Perspectives for Development of African Swine Fever Virus Vaccines | Vaccines | 2017 | 129 |
| 47 | A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants | Vaccines | 2021 | 126 |
| 48 | The Role of Extracellular Vesicles in Viral Infection and Transmission | Vaccines | 2019 | 124 |
| 49 | The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study | Vaccines | 2021 | 122 |
| 50 | Vector Design for Improved DNA Vaccine Efficacy, Safety and Production | Vaccines | 2013 | 118 |
